|
Originally published In Press as doi:10.1074/jbc.M107927200 on November 6, 2001
J. Biol. Chem., Vol. 277, Issue 5, 3168-3175, February 1, 2002
Composition of Drosophila melanogaster Proteome
Involved in Fucosylated Glycan Metabolism*
Christophe
Roos ,
Meelis
Kolmer ,
Pirkko
Mattila , and
Risto
Renkonen§¶ **
From MediCel Ltd., Haartmaninkatu 8, FIN-00290,
Helsinki, Finland, the § Rational Drug Design Program,
Biomedicum Helsinki, PB 63, FIN-00014 University of Helsinki, Finland,
the ¶ Department of Bacteriology and Immunology, Haartman
Institute, PB 63, FIN-00014 University of Helsinki, Finland, and
Helsinki University Central Hospital (HUCH)
Laboratory Diagnostics, FIN-00014 University of Helsinki, Finland
Received for publication, August 17, 2001, and in revised form, October 24, 2001
 |
ABSTRACT |
The whole genome approach enables the
characterization of all components of any given biological pathway.
Moreover, it can help to uncover all the metabolic routes for any
molecule. Here we have used the genome of Drosophila
melanogaster to search for enzymes involved in the metabolism of
fucosylated glycans. Our results suggest that in the fruit fly
GDP-fucose, the donor for fucosyltransferase reactions, is formed
exclusively via the de novo pathway from GDP-mannose
through enzymatic reactions catalyzed by GDP-D-mannose
4,6-dehydratase (GMD) and GDP-4-keto-6-deoxy-D-mannose 3,5-epimerase/4-reductase (GMER, also known as FX in man). The Drosophila genome does not have orthologs for the salvage
pathway enzymes, i.e. fucokinase and GDP-fucose
pyrophosphorylase synthesizing GDP-fucose from fucose. In addition we
identified two novel fucosyltransferases predicted to catalyze 1,3-
and 1,6-specific linkages to the GlcNAc residues on glycans. No
genes with the capacity to encode 1,2-specific fucosyltransferases
were found. We also identified two novel genes coding for
O-fucosyltransferases and a gene responsible for a
fucosidase enzyme in the Drosophila genome. Finally, using the Drosophila CG4435 gene, we identified two novel human
genes putatively coding for fucosyltransferases. This work can serve as
a basis for further whole-genome approaches in mapping all possible
glycosylation pathways and as a basic analysis leading to
subsequent experimental studies to verify the predictions made in this work.
 |
INTRODUCTION |
Glycans play an important role in a number of biological
processes. On the cellular level N-glycans are involved in
protein folding, quality control, and targeting (for a review, see Ref. 1). As constituents of the cell membrane and extracellular matrix
glycosylated proteins regulate through intercellular recognition and
signaling a plethora of biological processes such as fertilization, pattern formation during embryogenesis, hematopoiesis, neuronal development, wound healing, inflammation, tumor cell metastasis, host-microbial interactions, and infection (for reviews, see Refs. 2-9). O-Glycans are involved in signal transduction,
regulation of transcription, and translation (for reviews, see
Refs. 10 and 11).
Fucose is an essential component of various glycan structures. Perhaps
one of the most well known examples of molecules with fucose-containing
modifications ( 1,2-fucosylated lactosamine) are the ABO blood group
antigens. Other examples, representing the 1,3-fucosylated
modifications, are the sialyl Lewis x glycans, a crucial decoration of
selectin ligands. Sialyl Lewis x glycans have a central role in
inflammation, initiating extravasation of the leukocytes by mediating
their tethering and rolling on the endothelium (12). The
1,3-fucosylation has been shown to be involved in tumor
metastasizing via blood circulation (2). Further, fucosylated proteins
play an essential role during the normal development of an organism.
For example, the glycosylation of O-linked fucose of the
Notch receptor by Fringe has been shown to modulate the
Notch-dependent signaling pathway that establishes the
dorsoventral boundaries during embryogenesis of Drosophila (13, 14).
Fucosylation requires GDP-L-fucose, as the donor of fucose,
and fucosyltransferases, which catalyze the transfer of
L-fucose to the glycans or directly to serine/threonine
residues on the proteins that act as acceptors (15).
GDP-L-fucose can be synthesized in vivo either
via the de novo pathway from GDP-D-mannose or by the salvage pathway from fucose (16) (see Fig. 1). After synthesis in
the cytoplasm, the GDP-L-fucose is transported into the
Golgi apparatus by a specific transporter (17, 18). A number of enzymes, fucosyltransferases, acting in the Golgi and using
GDP-L-fucose as a donor have been characterized in various
species (19). Not only the fucosylation but also the degradation of
fucosylated glycans is an important step in fucose metabolism. The
removal of fucosylated glycans is catalyzed by fucosidases (for a
review, see Ref. 20). In humans, two inherited disorders caused by
defects of proteins involved in fucosylated glycan metabolism are
known. A congenital disorder of glycosylation of type IIc (OMIM
accession number 266265) is caused by mutation in the GDP-fucose
transporter gene and results in impaired GDP-L-fucose
transport to the Golgi (17, 18). An impaired lysosomal degradation of
fucosylated glycans caused by a defect in the
-L-fucosidase gene (FUCA1) leads to
fucosidosis, a recessive autosomal disorder (OMIM accession number
230000; Refs. 21 and 22).
An ever growing list of completely sequenced genomes offers a great
opportunity and challenge for systematic in silico searches for every component of any particular pathway. We have initiated an
effort to identify genes putatively involved in the metabolism of
various monosaccharides. We started out with the characterization of
the metabolic pathway of fucosylated glycans in Drosophila melanogaster. The fruit fly is a well studied model organism, and
its genome is the most comprehensively annotated genome of any
multicellular organism.
Experimental studies have shown that in the fruit fly fucose can be
attached to glycan acceptors through 1,6- and 1,3-linkage (23,
24). Recently O-linked fucose-containing glycoforms on the
Notch protein have been characterized (13, 14). Before this study
little was known of the Drosophila fucosylation on the
genomic level (for a review, see Ref. 25). Three recently described
1,3-fucosyltransferases are the only characterized genes involved in
fucosylation in the fruit fly (24). In addition a putative candidate
for the Drosophila GDP-fucose transporter has been inferred
from sequence homology (CG9620) (17, 18).
In this paper, we have used genome-wide bioinformatics to identify
enzymes involved in the synthesis of GDP-L-fucose, in the transfer of its sugar moiety to either glycans or protein
acceptors, and in degradation of fucosylated glycans.
 |
EXPERIMENTAL PROCEDURES |
The sequences used for homology searches were obtained from the
Swiss-Prot and TrEMBL data bases using the Sequence Retrieval System
(SRS) at the European Bioinformatics Institute (EBI, www.ebi.ac.uk/ and srs6.ebi.ac.uk/). The identifiers (accession numbers) are listed in Table I.
The homology searches were performed at Internet sites offering genome
information and tools. Most notably they were EBI, the National Center
for Biotechnology Information (NCBI, www.ncbi.nlm.nih.gov/), the
Berkeley Drosophila Genome Project (BDGP, www.fruitfly.org/), the
European Drosophila Genome Project (EDGP, edgp.ebi.ac.uk/) complemented by FlyBase (The FlyBase Consortium 1999, fly.ebi.ac.uk:7081/), and the Genome Annotation Database of Drosophila
(Gadfly, fly.ebi.ac.uk:7081/annot/).
The tools used for homology searches were Blast (26), Fasta (27), the
Smith-Waterman implementation, and programs available in the GCG
package (Wisconsin Package, version 10.0; Genetics Computer Group,
Madison, WI). DNA sequences were aligned with the program PILEUP
(Wisconsin Package, op. cit.) or with ClustalW (version 1.7 (28)) using an identity matrix, a gap weight of 8, and a gap length
weight of 0.1. Amino acid sequences were aligned with the same programs
using a Blosum32 protein weight matrix, a gap weight of 12, and a gap
length weight of 0.5. The DNA alignments were visually examined and
edited if needed using the GeneDoc program1 and corrected to
avoid alignments with disrupted reading frames. Trees were constructed
from the data using maximum parsimony and neighbor joining using
programs from the PHYLIP2 and
Treecon3 packages and the GCG
implementation of PAUP* (Wisconsin Package, op. cit.).
Heuristic searches were utilized in parsimony analyses due to the great
number of taxa examined. Branch swapping was done by tree
bisection-reconnection. For neighbor joining analyses, distance
measures (difference scores) were employed using a Kimura two-parameter
correction for multiple hits and a transition/transversion rate of two.
Bootstrap analyses (not shown) of 1000 replicates were performed to
examine the relative support of each relationship in the resultant
topologies. GeneDoc and TreeView (32) were used to prepare
illustrations of the alignments and the trees. Protein domains were
briefly investigated using Multiple EM for Motif Elicitation (MEME)
(33).4
 |
RESULTS AND DISCUSSION |
Synthesis of GDP-L-fucose--
Fucosylation requires a
nucleotide sugar, GDP-L-fucose, as the donor of fucose, and
enzymes, fucosyltransferases, which catalyze the transfer of
L-fucose onto the glycan or serines/threonines on proteins
acting as an acceptor (16). In mammals GDP-L-fucose can be
synthesized via two different pathways, either by the prominent de novo pathway or by the minor salvage pathway (Fig.
1).

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 1.
Schematic view of the synthesis of guanosine
5'-diphospho- -L-fucose
(GDP-fucose), which acts as the substrate of fucosyltransferases.
The dominating de novo pathway from GDP-mannose uses GMD and
GDP-4-keto-6-deoxy-D-mannose 3,5-epimerase/4-reductase for
the synthesis of GDP-fucose. An alternative salvage pathway uses
fucose, which is phosphorylated by fucokinase and then converted to
GDP-fucose by fucose-1-phosphate guanylyltransferase. The GDP-fucose is
then transported to the Golgi with a specific GDP-fucose
transporter.
|
|
The genes coding for enzymes in the de novo
pathway, GDP-D-mannose 4,6-dehydratase
(GMD)5 and
GDP-4-keto-6-deoxy-D-mannose 3,5-epimerase/4-reductase
(GMER or FX), have been cloned from bacteria, plants, and mammals (34). We used homology searches to identify CG8890 and CG3495 from the fly
genome as putative candidates for GMD and GMER, respectively (the
nucleotide sequence data base and FlyBase accession numbers along with
provisional annotations of all sequences described in this study are
shown in Table I). Multiple sequence
alignments of the conceptual Drosophila sequences with
previously known GMD and GMER proteins from a wide evolutionary range
of species reveal a high degree of amino acid conservation (Figs.
2 and 3). The Drosophila Gene
Collection (35) contains expressed sequence tag sequences
corresponding to both genes, proving that they are transcribed (Fig.
2B). Three P-element strains with the transposon (36)
residing in the 5' area of the CG8890 (gmd gene) were
identified in FlyBase. Two of these strains (l(2)k10001 and
l(2)k1003a) with a transposon inserted within 0.5 kb
upstream from the putative coding sequence are lethal (Fig.
2C), suggesting a vital role for the fruit fly gmd gene.
View this table:
[in this window]
[in a new window]
|
Table I
Fucosylated glycan metabolism pathway components depicted in this study
Prot., protein; Nt., nucleotide; NA, not applicable; ID, accession
number; A., Arabidopsis, E.,
Escherichia; C., Cricetulus;
H., Homo; M., Mus.
|
|

View larger version (68K):
[in this window]
[in a new window]
|
Fig. 2.
Genomic organization of the Drosophila
gmd gene. A, GENSCAN prediction
of a DNA segment from the chromosome 2L. The exon-intron structure of
the Dm-gmd (CG8890) gene is indicated by the
dark arrows. Two neighboring genes are also indicated by
light arrows. B, the location of a cDNA
(dashes: these are not sequenced). C, location of
three P-element insertions in the promoter of the Dm-gmd
gene. Two of them, l(2)k10001 and l(2)k10003a,
are lethal as shown by in vivo experiments. D,
alignment of selected gmd genes (known or predicted) ranging
from bacteria to humans. The shadings emphasize the degree
of conservation in each column in the alignment. The black
background highlights areas of 100% similarity, while the
gray background highlights areas of at least 80%
similarity. Amino acids are flagged as similar also in the case of
conservative substitutions. The shading has the same meaning in
subsequent figures.
|
|

View larger version (48K):
[in this window]
[in a new window]
|
Fig. 3.
Alignment of the Drosophila GMER
(CG3495) with some known or predicted GMER/FX ranging from bacteria to
humans via plants.
|
|
A salvage pathway is used as an alternative route for synthesizing
GDP-fucose from fucose in the absence of the de novo
pathway. We searched for the salvage pathway enzymes; however, the
mammalian fucokinase and fucose-1-phosphate guanylyltransferase failed
to identify any similar sequences in the fly genome. In
Drosophila, the presence of salvage GDP-L-fucose
synthesis pathways could be experimentally tested using available GMD
mutant strains (Fig. 2C).
Fucosyltransferases Using Glycan
Acceptors--
Fucosyltransferases have been characterized from
diverse phylogenetic origins ranging from bacteria to mammals. At least
10 human fucosyltransferases, located in the Golgi and yielding
1,2-, 1,3-, 1,4-, or 1,6-linkages on glycans or
O-linkage to serine and/or threonine have been identified.
Probes generated from human FUT1 and FUT2 both
with 1,2-specificity (37-39) did not find any significant relatives
from the Drosophila genome based on the primary sequence
analysis. It is somewhat surprising that, while both bacteria (40) and
mammals (41) carry 1,2-specific fucosylation, no signs
of genes belonging to this family could be depicted in the
Drosophila genome. In a nematode, Caenorhabditis
elegans, 13 1,2-fucosyltransferases have been predicted to
exist (19). However, our result is in good agreement with the fact that
in insects no 1,2-fucosylated glycans have been described so far
(for a review, see Ref. 5). It should also be noted that the loss of
1,2-fucosylation found in human H blood group-deficient individuals
(Bombay phenotype; OMIM accession number 211100) results in no apparent
phenotype (42). The absence of 1,2-fucosylation in
Drosophila can be explained by the ceasing of the particular
selection pressure that once promoted the emergence of this type of
modification (for a review, see Ref. 43).
Aligning all the human 1,3-fucosyltransferases, FUT3-7 and FUT9, we
identified four conserved sequences that were used as "baits" to
search the fly genome (Fig. 4). This
approach yielded three candidate genes from the Drosophila
genome (CG4435, CG6869, and CG9169) similar to mammalian genes. The
Drosophila Gene Collection (35) contains expressed sequence tag
sequences for all of them, proving that they are transcribed.

View larger version (83K):
[in this window]
[in a new window]
|
Fig. 4.
Alignment of the four most conserved areas
(I-IV) of the human and mouse
1,3-fucosyltransferases and the three putative
novel Drosophila fucosyltransferases. The two Lys
residues in domain III (arrowheads) have been shown to be
required for enzymatic activity and for substrate binding (30,
31).
|
|
No P-element insertion phenotypes were identified for any of the genes
in FlyBase. Alignments of the conceptual translation of CG4435, CG6869,
and CG9169 to known mammalian fucosyltransferases of known
1,3/1,4-specificity showed several conserved stretches/domains (Fig.
4). Of the three genes, CG9169 was the most divergent as compared with
the mammalian transferases. Nevertheless, a search performed with
CG9169 listed the human fucosyltransferase FUT3 (44) as the most
similar known protein to CG9169. Pairwise similarity analysis of the
CG9169 and FUT3 sequences showed that the area of similarity is located
in the carboxyl-terminal part of the protein (Fig.
5). The fact that the
Drosophila genome contains several novel candidate
1,3-fucosyltransferases indicates that 1,3-fucosylated glycans
are vital in the fruit fly.

View larger version (57K):
[in this window]
[in a new window]
|
Fig. 5.
Pairwise comparison of the fly CG9169
predicted peptide with the human FucT-3. The shaded
areas represent conserved amino acid sequence stretches. The
conserved domains I, III, and IV in
Fig. 4 are marked in the human sequence with brackets and
numbers. This analysis indicates that the amino acid
sequence of the last half of the CG9169 peptide is similar to that of
their human 1,3-fucosyltransferases FucT-3 (FUT3)
counterparts. aa, amino acids.
|
|
We searched public sequence data bases to identify human candidates
encoding for additional fucosyltransferases using as a query the
Drosophila sequence CG4435 characterized in this
study. The two best candidates represented novel
fucosyltransferases and were termed FUT10 and FUT11 (the NCBI
RefSeq data base accession numbers NT_008076 and NT_024037,
respectively). The human FUT10 and FUT11 showed higher sequence
similarity to the Drosophila probe than to any characterized
human fucosyltransferase sequence (Fig.
6).

View larger version (87K):
[in this window]
[in a new window]
|
Fig. 6.
Alignment of the fucosyltransferases with
putative 1,3-specificity from human and fly
(CG-prefixed lines for the fly). A, the alignment
encompassing the conserved area of the protein. B, four
motifs suggested by the MEME pattern discovery tool are indicated on a
schematic overview. The third box (marked "III" in both
A and B) corresponds to an area considered
characteristic for fucosyltransferases.
|
|
The human fucosyltransferase FUT8 has a 1,6-specific activity to the
proximal GlcNAc residue on N-linked glycans. Thus, this enzyme participates in the synthesis of hybrid and complex types of
N-glycans on glycoproteins. FUT8 is widely expressed in
mammalian tissues, and it has distinctly high expression during fetal
development and in liver tumors (45). Our homology searches identified
the gene CG2448 as the best ortholog candidate with a significant sequence similarity of over 75% to the human FUT8 (Fig.
7).

View larger version (60K):
[in this window]
[in a new window]
|
Fig. 7.
Alignment of the human, mouse, and putative
fly 1,6-fucosyltransferases (Fuc-T8/CG2448)
showing a high level of similarity between the invertebrate and
mammalian enzymes.
|
|
In an attempt to refine the function of the novel genes and get an even
more substantial handle on their putative specificities, the DNA
sequence from the coding area of fly, human, and rodent genes
were aligned, and all pairwise distances were calculated using standard
phylogenetic tools. The resulting unrooted tree visualization of the
distances (Fig. 8) confirmed the
observations: CG2448 was closely related to human and mouse FUT8 with
1,6-transferase activity, while the other three new fly genes belong
to a larger group with 1,3- or 1,3/4-specific transferase
activity. Furthermore, our phylogenetic analysis suggests that two
novel human enzymes (FUT10 and FUT11) may belong to an evolutionary
distinct group of fucosyltransferases (Fig. 8). This distinct
clustering may reflect a difference either in enzyme activity or
acceptor specificity. Nevertheless, the closest relatives to this group
are the 1,3/1,4-fucosytransferases, so we favor the latter
possibility.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 8.
Phylogenetic analysis of the known and
predicted human (indicated by Fut numbers) and mouse (indicated by *)
and putative Drosophila fucosyltransferases (indicated
by CG numbers). The analysis clusters the polypeptides based on
the their distance to each other, measured in numbers of mutations per
site. The clustering follows the known enzyme activities indicated by
the numbers. The scale indicates distances in number of mutations per
site.
|
|
Recent experiments have shown that CG4435 and CG6869 have core
1,3-fucosyltransferase activity (24). In the same study a gene
encoding for 1,3-fucosyltransferase, neglected by our homology
searches, was characterized (EMBL/GenBankTM/DDJB nucleotide sequence
accession number AJ302047) (24).
Drosophila O-Fucosyltransferases--
In addition to glycans the
proteins also can directly be fucosylated at serine/threonine residues
(for a review, see Ref. 15). O-Linked fucose exists both as
a monosaccharide or elongated glycoform. It has been shown in
Drosophila that the elongation of O-linked fucose
(by addition of GlcNAc) of Notch receptor by Fringe has a crucial role
in modulating its affinity toward Delta and Serrate ligands. Notch
signaling is important in establishing the dorsoventral boundaries
during embryogenesis (13, 14). So far no
O-fucosyltransferase, an enzyme providing the acceptor for
the reaction catalyzed by Fringe, has been described in
Drosophila. Recently a human O-fucosyltransferase
has been identified by Wang and Spellman (29). We have searched the
Drosophila genome using partial sequence data from this
patent and identified two putative candidates for
O-fucosyltransferase: CG12366 and CG14789, called O-FUT1 and O-FUT2 here (Fig.
9). Both of these predicted genes are
active as can be deduced from the existence of similar expressed sequence tag sequences in the data bases. No P-element insertions were
found in these genes in the FlyBase.

View larger version (60K):
[in this window]
[in a new window]
|
Fig. 9.
Alignment of the putative
O-fucosyltransferases from human and fly (CG-prefixed
lines). The alignment emphasizes the groupwise similarity between
the "1-type" (upper two) and the "2-type"
(lower two) families and the low overall similarity between
the families. Three motifs suggested by the MEME motif discovery tool
are indicated by Roman numerals I, II, and
III.
|
|
Degradation of Fucosylated Glycans--
The degradation of
fucosylated glycans is an important step in fucose metabolism, and
defects in the human -L-fucosidase gene
(FUCA1) result in fucosidosis, a recessive autosomal
disorder (21, 22). We looked for fucosidases in the
Drosophila genome using human -L-fucosidase
(FUCA1) as the "bait" and identified CG6128 as the ortholog gene.
The alignment of the Drosophila putative fucosidase with
human and rat counterparts (including Q9UJM5, a human protein similar
to fucosidase) is shown in Fig. 10.

View larger version (61K):
[in this window]
[in a new window]
|
Fig. 10.
Alignment of the previously
identified human (FUCA1) and rat fucosidases with a putative novel
fucosidase from man (TrEMBL accession number Q9UJM5) and
Drosophila (CG6128).
|
|
Conclusions--
In this study we have applied computational
methods to characterize the molecular pathways responsible for
fucosylation of cellular proteins in a whole-genome-wide manner in
D. melanogaster. We have identified two novel enzymes
putatively involved in the synthesis of GDP-L-fucose. Our
data suggest that in the fruit fly fucose is formed solely through the
de novo GDP-fucose synthesis pathway with no salvage pathway
present. A putative candidate for the Drosophila GDP-fucose
transporter has been previously inferred from sequence homology
(CG9620) (17, 18). We further identified two novel fucosyltransferases
predicted to catalyze 1,3- and 1,6-specific linkages, two
O-fucosyltransferases, and one fucosidase gene in the
Drosophila genome. The Drosophila genome has
apparently no genes encoding for 1,2-specific fucosyltransferases. Finally, we have identified two novel human putative
N-fucosyltransferase sequences using one of the newly
detected Drosophila fucosyltransferase as a query sequence.
Our results show that new members of protein families of the same
organism can readily be identified using homology searches that
traverse the genomes of different species. This work can serve as the
basis for further whole-genome approaches in mapping all possible
glycosylation pathways, and it can also serve as the basic analysis
leading to experimental studies verifying the predictions made in this work.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Ossi Renkonen for
comments and fruitful discussions. Donald Smart is acknowledged for
language revision.
 |
FOOTNOTES |
*
This work was supported by grants from the Academy of
Finland, Technology Development Center of Finland, Sigrid Juselius
Foundation, and the HUCH Research Fund (to R. R.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
**
To whom correspondence should be addressed: Rational Drug Design
Program, Biomedicum Helsinki, PB 63, FIN-00014 University of Helsinki,
Finland. Tel.: 358-9-19125111; Fax: 358-9-19125155; E-mail:
risto.renkonen@helsinki.fi.
Published, JBC Papers in Press, November 6, 2001, DOI 10.1074/jbc.M107927200
1
K. Nicholas and H. J. Nicholas,
www.psc.edu/biomed/genedoc.
2
J. Felsentstein,
evolution.genetics.washington.edu/phylip/phylip.html.
3
Y. Van de Peer and R. De Wachter,
www.uia.ac.be/u/yvdp/treeconw.html.
4
MEME can be found at
meme.sdsc.edu/meme.3.0/website/.
 |
ABBREVIATIONS |
The abbreviations used are:
GMD, GDP-D-mannose 4,6-dehydratase;
GMER or FX, GDP-4-keto-6-deoxy-D-mannose 3,5-epimerase/4-reductase.
 |
REFERENCES |
| 1.
|
Helenius, A.,
and Aebi, M.
(2001)
Science
291,
2364-2369[Abstract/Free Full Text]
|
| 2.
|
McEver, R. P.
(1997)
Glycoconj. J.
14,
585-591[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Iozzo, R. V.
(1998)
Annu. Rev. Biochem.
67,
609-652[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Dell, A.,
Morris, H. R.,
Easton, R. L.,
Patankar, M.,
and Clark, G. F.
(1999)
Biochim. Biophys. Acta
1473,
196-205[Medline]
[Order article via Infotrieve]
|
| 5.
|
Staudacher, E.,
Altmann, F.,
Wilson, I. B.,
and Marz, L.
(1999)
Biochim. Biophys. Acta
1473,
216-236[Medline]
[Order article via Infotrieve]
|
| 6.
|
Scheid, A.,
Meuli, M.,
Gassmann, M.,
and Wenger, R. H.
(2000)
Exp. Physiol.
85,
687-704[Abstract]
|
| 7.
|
Hooper, L. V.,
and Gordon, J. I.
(2001)
Glycobiology
11,
1R-10R[Abstract/Free Full Text]
|
| 8.
|
Lowe, J. B.
(2001)
Cell
104,
809-812[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Rudd, P. M.,
Elliott, T.,
Cresswell, P.,
Wilson, I. A.,
and Dwek, R. A.
(2001)
Science
291,
2370-2376[Abstract/Free Full Text]
|
| 10.
|
Hanover, J. A.
(2001)
FASEB J.
15,
1865-1876[Abstract/Free Full Text]
|
| 11.
|
Wells, L.,
Vosseller, K.,
and Hart, G. W.
(2001)
Science
291,
2376-2378[Abstract/Free Full Text]
|
| 12.
|
Lowe, J. B.,
and Ward, P. A.
(1997)
J. Clin. Invest.
99,
822-826[Medline]
[Order article via Infotrieve]
|
| 13.
|
Bruckner, K.,
Perez, L.,
Clausen, H.,
and Cohen, S.
(2000)
Nature
406,
411-415[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Moloney, D. J.,
Panin, V. M.,
Johnston, S. H.,
Chen, J.,
Shao, L.,
Wilson, R.,
Wang, Y.,
Stanley, P.,
Irvine, K. D.,
Haltiwanger, R. S.,
and Vogt, T. F.
(2000)
Nature
406,
369-375[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Harris, R. J.,
and Spellman, M. W.
(1993)
Glycobiology
3,
219-224[Abstract/Free Full Text]
|
| 16.
|
Becker, D. J.,
and Lowe, J. B.
(1999)
Biochim. Biophys. Acta
1455,
193-204[Medline]
[Order article via Infotrieve]
|
| 17.
|
Lubke, T.,
Marquardt, T.,
Etzioni, A.,
Hartmann, E.,
von Figura, K.,
and Korner, C.
(2001)
Nat. Med.
28,
73-76
|
| 18.
|
Luhn, K.,
Wild, M. K.,
Eckhardt, M.,
Gerardy-Schahn, R.,
and Vestweber, D.
(2001)
Nat. Genet.
28,
69-72[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Oriol, R.,
Mollicone, R.,
Cailleau, A.,
Balanzino, L.,
and Breton, C.
(1999)
Glycobiology
9,
323-334[Abstract/Free Full Text]
|
| 20.
|
Johnson, S. W.,
and Alhadeff, J. A.
(1991)
Comp. Biochem. Physiol. B
99,
479-488[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Fleming, C. J.,
Sinclair, D. U.,
White, E. J.,
Winchester, B.,
Whiteford, M. L.,
and Connor, J. M.
(1998)
J. Inherit. Metab. Dis.
21,
688-689[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Veeramachaneni, D. N.,
Smith, M. O.,
and Ellinwood, N. M.
(1998)
J. Androl.
19,
444-449[Abstract/Free Full Text]
|
| 23.
|
Williams, P. J.,
Wormald, M. R.,
Dwek, R. A.,
Rademacher, T. W.,
Parker, G. F.,
and Roberts, D. R.
(1991)
Biochim. Biophys. Acta
1075,
146-153[Medline]
[Order article via Infotrieve]
|
| 24.
|
Fabini, G.,
Freilinger, A.,
Altmann, F.,
and Wilson, I. B.
(2001)
J. Biol. Chem.
276,
28058-28067[Abstract/Free Full Text]
|
| 25.
|
Seppo, A.,
and Tiemeyer, M.
(2000)
Glycobiology
10,
751-760[Abstract/Free Full Text]
|
| 26.
|
Altschul, S. F.,
Madden, T. L.,
Schaffer, A. A.,
Zhang, J.,
Zhang, Z.,
Miller, W.,
and Lipman, D. J.
(1997)
Nucleic Acids Res.
25,
3389-3402[Abstract/Free Full Text]
|
| 27.
|
Pearson, W. R.
(1990)
Methods Enzymol.
183,
63-98[Medline]
[Order article via Infotrieve]
|
| 28.
|
Thompson, J. D.,
Higgins, D. G.,
and Gibson, T. J.
(1994)
Nucleic Acids Res.
22,
4673-4680[Abstract/Free Full Text]
|
| 29.
|
Wang, Y.,
Shao, L.,
Shi, S.,
Harris, R. J.,
Spellman, M. W.,
Stanley, P.,
and Haltiwanger, R. S.
(2001)
J. Biol. Chem.
276,
40338-40345[Abstract/Free Full Text]
|
| 30.
|
Sherwood, A. L.,
Nguyen, A. T.,
Whitaker, J. M.,
Macher, B. A.,
Stroud, M. R.,
and Holmes, E. H.
(1998)
J. Biol. Chem.
273,
25256-25260[Abstract/Free Full Text]
|
| 31.
|
Sherwood, A. L.,
Davis, W. C., Ho, S.,
Macher, B. A.,
Stroud, M. R.,
Upchurch, D. A.,
and Holmes, E. H.
(2000)
Biochem. Biophys. Res. Commun.
273,
870-876[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Page, R. D.
(1996)
Comput. Appl. Biosci.
12,
357-358[Free Full Text]
|
| 33.
|
Bailey, T. L.,
and Gribskov, M.
(1998)
J. Comput. Biol.
5,
211-221[Medline]
[Order article via Infotrieve]
|
| 34.
|
Tonetti, M.,
Sturla, L.,
Bisso, A.,
Zanardi, D.,
Benatti, U.,
and De Flora, A.
(1998)
Biochimie (Paris)
80,
923-931[Medline]
[Order article via Infotrieve]
|
| 35.
|
Rubin, G. M.,
Hong, L.,
Brokstein, P.,
Evans-Holm, M.,
Frise, E.,
Stapleton, M.,
and Harvey, D. A.
(2000)
Science
287,
2222-2224[Abstract/Free Full Text]
|
| 36.
|
Spradling, A. C.,
Stern, D.,
Beaton, A.,
Rhem, E. J.,
Laverty, T.,
Mozden, N.,
Misra, S.,
and Rubin, G. M.
(1999)
Genetics
153,
135-177[Abstract/Free Full Text]
|
| 37.
|
Larsen, R. D.,
Ernst, L. K.,
Nair, R. P.,
and Lowe, J. B.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
6674-6678[Abstract/Free Full Text]
|
| 38.
|
Rouquier, S.,
Lowe, J. B.,
Kelly, R. J.,
Fertitta, A. L.,
Lennon, G. G.,
and Giorgi, D.
(1995)
J. Biol. Chem.
270,
4632-4639[Abstract/Free Full Text]
|
| 39.
|
Kelly, R. J.,
Rouquier, S.,
Giorgi, D.,
Lennon, G. G.,
and Lowe, J. B.
(1995)
J. Biol. Chem.
270,
4640-4649[Abstract/Free Full Text]
|
| 40.
|
Wang, G.,
Boulton, P. G.,
Chan, N. W.,
Palcic, M. M.,
and Taylor, D. E.
(1999)
Microbiology
145,
3245-3253[Abstract/Free Full Text]
|
| 41.
|
Domino, S. E.,
Zhang, L.,
and Lowe, J. B.
(2001)
J. Biol. Chem.
276,
23748-23756[Abstract/Free Full Text]
|
| 42.
|
Kelly, R. J.,
Ernst, L. K.,
Larsen, R. D.,
Bryant, J. G.,
Robinson, J. S.,
and Lowe, J. B.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
5843-5847[Abstract/Free Full Text]
|
| 43.
|
Gagneux, P.,
and Varki, A.
(1999)
Glycobiology
9,
747-755[Abstract/Free Full Text]
|
| 44.
|
Kukowska-Latallo, J. F.,
Larsen, R. D.,
Nair, R. P.,
and Lowe, J. B.
(1990)
Genes Dev.
4,
1288-1303[Abstract/Free Full Text]
|
| 45.
|
Miyoshi, E.,
Noda, K.,
Yamaguchi, Y.,
Inoue, S.,
Ikeda, Y.,
Wang, W., Ko, J. H.,
Uozumi, N., Li, W.,
and Taniguchi, N.
(1999)
Biochim. Biophys. Acta
1473,
9-20[Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Ohata, S. Kinoshita, R. Aoki, H. Tanaka, H. Wada, S. Tsuruoka-Kinoshita, T. Tsuboi, S. Watabe, and H. Okamoto
Neuroepithelial cells require fucosylated glycans to guide the migration of vagus motor neuron progenitors in the developing zebrafish hindbrain
Development,
May 15, 2009;
136(10):
1653 - 1663.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Mollicone, S. E. H. Moore, N. Bovin, M. Garcia-Rosasco, J.-J. Candelier, I. Martinez-Duncker, and R. Oriol
Activity, Splice Variants, Conserved Peptide Motifs, and Phylogeny of Two New {alpha}1,3-Fucosyltransferase Families (FUT10 and FUT11)
J. Biol. Chem.,
February 13, 2009;
284(7):
4723 - 4738.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Stahl, K. Uemura, C. Ge, S. Shi, Y. Tashima, and P. Stanley
Roles of Pofut1 and O-Fucose in Mammalian Notch Signaling
J. Biol. Chem.,
May 16, 2008;
283(20):
13638 - 13651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Shi, C. Ge, Y. Luo, X. Hou, R. S. Haltiwanger, and P. Stanley
The Threonine That Carries Fucose, but Not Fucose, Is Required for Cripto to Facilitate Nodal Signaling
J. Biol. Chem.,
July 13, 2007;
282(28):
20133 - 20141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Sasamura, H. O. Ishikawa, N. Sasaki, S. Higashi, M. Kanai, S. Nakao, T. Ayukawa, T. Aigaki, K. Noda, E. Miyoshi, et al.
The O-fucosyltransferase O-fut1 is an extracellular component that is essential for the constitutive endocytic trafficking of Notch in Drosophila
Development,
April 1, 2007;
134(7):
1347 - 1356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. D. Barrows, S. M. Haslam, L. J. Bischof, H. R. Morris, A. Dell, and R. V. Aroian
Resistance to Bacillus thuringiensis Toxin in Caenorhabditis elegans from Loss of Fucose
J. Biol. Chem.,
February 2, 2007;
282(5):
3302 - 3311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Sasaki, T. Sasamura, H. O. Ishikawa, M. Kanai, R. Ueda, K. Saigo, and K. Matsuno
Polarized exocytosis and transcytosis of Notch during its apical localization in Drosophila epithelial cells.
Genes Cells,
January 1, 2007;
12(1):
89 - 103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Ma, J. L. Simala-Grant, and D. E. Taylor
Fucosylation in prokaryotes and eukaryotes
Glycobiology,
December 1, 2006;
16(12):
158R - 184R.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sawa, T.-L. Hsu, T. Itoh, M. Sugiyama, S. R. Hanson, P. K. Vogt, and C.-H. Wong
Glycoproteomic probes for fluorescent imaging of fucosylated glycans in vivo
PNAS,
August 15, 2006;
103(33):
12371 - 12376.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Luo, K. Koles, W. Vorndam, R. S. Haltiwanger, and V. M. Panin
Protein O-Fucosyltransferase 2 Adds O-Fucose to Thrombospondin Type 1 Repeats
J. Biol. Chem.,
April 7, 2006;
281(14):
9393 - 9399.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. O. Ishikawa, S. Higashi, T. Ayukawa, T. Sasamura, M. Kitagawa, K. Harigaya, K. Aoki, N. Ishida, Y. Sanai, and K. Matsuno
Notch deficiency implicated in the pathogenesis of congenital disorder of glycosylation IIc
PNAS,
December 20, 2005;
102(51):
18532 - 18537.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Wang, S. Inoue, J. Gu, E. Miyoshi, K. Noda, W. Li, Y. Mizuno-Horikawa, M. Nakano, M. Asahi, M. Takahashi, et al.
From The Cover: Dysregulation of TGF-{beta}1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice
PNAS,
November 1, 2005;
102(44):
15791 - 15796.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Huopaniemi, M. Kolmer, J. Niittymaki, M. Pelto-Huikko, and R. Renkonen
Inflammation-induced transcriptional regulation of Golgi transporters required for the synthesis of sulfo sLex glycan epitopes
Glycobiology,
December 1, 2004;
14(12):
1285 - 1294.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Maki and R. Renkonen
Biosynthesis of 6-deoxyhexose glycans in bacteria
Glycobiology,
March 1, 2004;
14(3):
1R - 15R.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Martinez-Duncker, R. Mollicone, J.-J. Candelier, C. Breton, and R. Oriol
A new superfamily of protein-O-fucosyltransferases, {alpha}2-fucosyltransferases, and {alpha}6-fucosyltransferases: phylogeny and identification of conserved peptide motifs
Glycobiology,
December 1, 2003;
13(12):
1C - 5C.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Sasamura, N. Sasaki, F. Miyashita, S. Nakao, H. O. Ishikawa, M. Ito, M. Kitagawa, K. Harigaya, E. Spana, D. Bilder, et al.
neurotic, a novel maternal neurogenic gene, encodes an O-fucosyltransferase that is essential for Notch-Delta interactions
Development,
October 15, 2003;
130(20):
4785 - 4795.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Becker and J. B. Lowe
Fucose: biosynthesis and biological function in mammals
Glycobiology,
July 1, 2003;
13(7):
41R - 53R.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. L. Smith, J. T. Myers, C. E. Rogers, L. Zhou, B. Petryniak, D. J. Becker, J. W. Homeister, and J. B. Lowe
Conditional control of selectin ligand expression and global fucosylation events in mice with a targeted mutation at the FX locus
J. Cell Biol.,
August 19, 2002;
158(4):
801 - 815.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Renkonen, O. Tynninen, P. Hayry, T. Paavonen, and R. Renkonen
Glycosylation Might Provide Endothelial Zip Codes for Organ-Specific Leukocyte Traffic into Inflammatory Sites
Am. J. Pathol.,
August 1, 2002;
161(2):
543 - 550.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|